Lipid and Corticosteroid Biomarkers Under the Influence of Bisphosphonates
Drug Testing and Analysis · 2025
DOI: 10.1002/dta.3811 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Testing and Analysis, 2025. Verfasst von Kathy Tou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Forensic Science, University of Technology Sydney, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Diphosphonates, Adrenal Cortex Hormones, Substance Abuse Detection, Bone Density Conservation Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Detecting the use of bisphosphonates (BPs) in equine athletes is of interest to regulators and laboratories due to the threat to welfare issues for the potential to provide analgesic effects and manipulating bone structure. The detection of BPs in biological matrices is challenging due to erratic biological elimination and inconsistent analytical recoveries. Therefore, complementary approaches are needed to provide evidence of their misuse in racehorses. BPs have two sub‐classes: nitrogenous and non‐nitrogenous. This study investigated plasma elimination following administration of one example from each sub‐class, together with changes in endogenous eicosanoid and corticosteroids. Zoledronic acid (ZA) and tiludronic acid (TA) were administered by IV infusion to 8 thoroughbred horses with an 11‐month washout period between each administration. Sample preparation for quantification of BPs by liquid chromatography–tandem mass spectrometry (LC–MS/MS) utilised a two‐step solid phase extraction (SPE) consisting of polymeric reversed‐phase followed by weak anion exchange prior to derivatisation using trimethyl orthoacetate. Endogenous biomarkers were analysed after protein precipitation and SPE with polymeric reversed‐phase prior to liquid chromatography–high resolution mass spectrometry (LC‐HRMS) using data independent acquisition. The LC–MS/MS analysis showed ZA was undetectable after 8 h post‐administration while TA was detected up to the final collection point of 28 days post‐administration. The LC‐HRMS analysis utilised targeted (i.e., prior inclusion list of compounds) approaches to monitor level changes of eicosanoid and corticosteroid biomarkers. Putative biomarkers were identified and now subject to validation for translation into routine sample analysis for improved retrospectivity to detecting BP misuse in equine plasma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Forensic Science, University of Technology Sydney, Sydney, New South Wales, Australia.
- Racing Analytical Services Ltd, Flemington, Victoria, Australia.
- School of Veterinary Sciences, Charles Sturt University, Wagga Wagga, New South Wales, Australia.
- Hyphenated Mass Spectrometry Laboratory, University of Technology Sydney, Sydney, New South Wales, Australia.
- Australian Racing Forensic Laboratory, Racing NSW, Sydney, New South Wales, Australia.
ORCID-Profile: Kathy Tou, Adam Cawley, Jaymie Loy, Stacey Richards, Shanlin Fu
Zitieren
APA
Tou, K., Cawley, A., Noble, G., Loy, J., Bishop, D., Keledjian, J., Sornalingam, K., Richards, S., & Fu, S. (2025). Lipid and Corticosteroid Biomarkers Under the Influence of Bisphosphonates. Drug Testing and Analysis. https://doi.org/10.1002/dta.3811
Vancouver
Tou K, Cawley A, Noble G, Loy J, Bishop D, Keledjian J, et al. Lipid and Corticosteroid Biomarkers Under the Influence of Bisphosphonates. Drug Testing and Analysis. 2025. doi:10.1002/dta.3811
BibTeX
@article{Tou2025,
author = {Tou, Kathy and Cawley, Adam and Noble, Glenys and Loy, Jaymie and Bishop, David and Keledjian, John and Sornalingam, Kireesan and Richards, Stacey and Fu, Shanlin},
title = {Lipid and Corticosteroid Biomarkers Under the Influence of Bisphosphonates},
journal = {Drug Testing and Analysis},
year = {2025},
doi = {10.1002/dta.3811}
}
EUVIMED